Session » (1796–1826) Epidemiology & Public Health Poster III
- 9:00AM-11:00AM
-
Abstract Number: 1810
Alcohol Consumption Amount, Type of Beverage, and Gender, All Matters to Serum Uric Acid Levels
- 9:00AM-11:00AM
-
Abstract Number: 1813
Assessing Immunogenicity of SARS-CoV-2 Vaccine Neoantigen S1 in Autoimmune Rheumatic Disease Patients: A Study on Cellular and Humoral Responses
- 9:00AM-11:00AM
-
Abstract Number: 1798
Association Between Knee Osteoarthritis and Mortality: A Serial Propensity Score-matched Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1799
Association of Pregabalin vs Gabapentin with Incident Congestive Heart Failure in Patients with Non-Cancer Pain
- 9:00AM-11:00AM
-
Abstract Number: 1824
Breakthrough COVID-19 and Severity After Vaccination Among Pregnant Persons with Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1819
Clinical Indications Associated with New Opioid Use for Pain Management in the United Kingdom Using National Primary Care Data
- 9:00AM-11:00AM
-
Abstract Number: 1809
Clinical Outcome and Antibody Responses Following the Surge of SARS-CoV-2 Omicron Infection Among Patients with Systemic Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1818
Compliance with Romosozumab and Fracture Risk Among Postmenopausal Women in the U.S
- 9:00AM-11:00AM
-
Abstract Number: 1812
Duloxetine and the Risk for Cardiovascular Events in US Veterans with Non-Cancer Pain
- 9:00AM-11:00AM
-
Abstract Number: 1825
Exploring the Health and Cannabis Use Among Young and Middle-Aged Adults with Rheumatologic Conditions in Alberta, Canada
- 9:00AM-11:00AM
-
Abstract Number: 1800
Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1797
Factors Associated with Distress Related to Perceived Dignity in Patients with Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1817
Geographic Variability of Inflammatory Bowel Disease Related Mortality, 1999-2019; CDC WONDER
- 9:00AM-11:00AM
-
Abstract Number: 1823
Higher Body Mass Index and Older Age, Both of Which Are Linked to Immunothrombosis Are Associated with Improved Survival with Baricitinib Therapy in COVID-19 Pneumonia
- 9:00AM-11:00AM
-
Abstract Number: 1816
Hyperuricemia – Especially “Metabolic Hyperuricemia” – Is Independently Associated with Higher Risk of Fatty Liver
- 9:00AM-11:00AM
-
Abstract Number: 1807
Hypothyroidism Impacts Clinical and Healthcare Utilization Outcomes After Primary Total Hip Arthroplasty
- 9:00AM-11:00AM
-
Abstract Number: 1826
Investigating the Health Profiles and the Prevalence and Correlates of Cannabis Use Among Patients Accessing Rheumatologic Care in Alberta, Canada
- 9:00AM-11:00AM
-
Abstract Number: 1805
Longitudinal Changes in Serum Urate Associate Minimally with Changes in Daily Alcohol Intake
- 9:00AM-11:00AM
-
Abstract Number: 1803
Perceived Dignity in Patients with Rheumatic Diseases: An Unrecognized Source of Emotional Distress
- 9:00AM-11:00AM
-
Abstract Number: 1804
Plant-based Diet Quality and the Risk of Gout: Results from Two Prospective Cohort Studies of US Men and Women
- 9:00AM-11:00AM
-
Abstract Number: 1802
Rheumatologic Disorder Diagnostic Testing Patterns:Real World Evidence from a National Laboratory Database
- 9:00AM-11:00AM
-
Abstract Number: 1796
Safety & ImmUnogenicity of COVID-19 VaCcines in SystEmic immunE Mediated Inflammatory Diseases (SUCCEED)
- 9:00AM-11:00AM
-
Abstract Number: 1814
Silica and Other Exposures from Jobs and Hobbies Are Associated with Myositis Phenotype in a National Myositis Registry
- 9:00AM-11:00AM
-
Abstract Number: 1820
Statewide Burden of Osteoarthritis in United States Between 1990-2019: A Systematic and Comparative Benchmarking Study
- 9:00AM-11:00AM
-
Abstract Number: 1811
Strong Relationships Between Body Component Changes and Serum Uric Acid Variability
- 9:00AM-11:00AM
-
Abstract Number: 1821
The “Weekend Effect” and Rheumatological Association in Patients with Diffuse Alveolar Haemorrhage
- 9:00AM-11:00AM
-
Abstract Number: 1815
The Association of Body Mass Index with SARS-CoV-2 Infection (COVID-19) in Patients with Inflammatory Arthritis on Biologic Disease Modifying Anti-Rheumatic Drugs: Results from the Singapore National Biologics Register
- 9:00AM-11:00AM
-
Abstract Number: 1822
The Food and Drug Administration’s (FDA’s) Safety Surveillance of Baricitinib and Tocilizumab for COVID-19 (Disclaimer: This Abstract Reflects the Views of the Authors and Not Necessarily Those of the US FDA)
- 9:00AM-11:00AM
-
Abstract Number: 1806
The Prevalence of Cardiac Sarcoidosis – A Systemic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1801
Tixagevimab/Cilgavimab for the Prevention of COVID-19 in Vaccine-refractory Patients with Autoimmune Diseases: A Prospective Cohort Study